AlphaFold predicted structure
GDF11 · O95390

Mean pLDDT
73.1/ 100
Confident
407 residues
Confidence breakdown
- Very high(≥ 90)28%
- Confident(70–90)36%
- Low(50–70)17%
- Very low(< 50)20%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
growth differentiation factor 11
Annotations refreshed 9 hours ago.
Diagnostic Grade (Green)
Clefting
MONOALLELIC, autosomal or pseudoautosomal, NOT imprintedDDG2P
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownFetal anomalies
MONOALLELIC, autosomal or pseudoautosomal, NOT imprintedCurrarino triad
Unknownvertebral hypersegmentation and orofacial anomalies
orofacial cleft
neurodegenerative disease
neurodevelopmental disorder
chronic obstructive pulmonary disease
hepatocellular carcinoma
major depressive disorder
neoplasm
schizophrenia
familial dilated cardiomyopathy
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Growth/differentiation factor 11
Secreted signal that acts globally to regulate anterior/posterior axial patterning during development. May play critical roles in patterning both mesodermal and neural tissues (By similarity). It is required for proper vertebral patterning and orofacial development (PubMed:31215115). Signals through activin receptors type-2, ACVR2A and ACVR2B, and activin receptors type-1, ACVR1B, ACVR1C and TGFBR1 leading to the phosphorylation of SMAD2 and SMAD3 (PubMed:28257634)
GDF11 · O95390

Mean pLDDT
73.1/ 100
Confident
407 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0